Overview
- 18 inspections across 18 sites are on record.
- 14 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2020-01-24.
At a glance
Inspections
18
Sites
18
Observations
14
Career since
Mar 2009
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Lonza Bend Inc. | 24 Jan 2020 | Human Drugs | On file |
| Synthon Bv | 26 Feb 2014 | Human Drugs | |
| Pentapharm Ag | 20 Feb 2014 | Human Drugs | |
| Merck & Cie KmG | 14 Feb 2014 | Human Drugs | |
| SGS Institut Fresenius GmbH | 26 Sep 2012 |
Sites inspected
Lonza Bend Inc.Bend, United States1 insp.
Synthon BvNijmegen, Netherlands1 insp.
Pentapharm AgAesch BL, Switzerland1 insp.
Merck & Cie KmGSchaffhausen, Switzerland1 insp.
SGS Institut Fresenius GmbHTaunusstein, Germany1 insp.
Co-investigators
Investigators who share inspections with this person.
Simone E Pitts5 shared
Nancy G Schmidt4 shared
Donna F Campbell3 shared
Kelli F Dobilas3 shared
S. L Brown2 shared
Nicholas L Hunt1 shared
Full investigator report
Get the verbatim findings behind Anissa M Vargas' 14 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site